Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Omalizumab is injected in the upper arm every two to four weeks. The dose of omalizumab received will depend upon the patient’s body weight and the result of a blood test to measure their IgE level. Unless a patient’s weight changes significantly, the dose and timings of their injection will not change.
